1. Home
  2. ABT vs TMUS Comparison

ABT vs TMUS Comparison

Compare ABT & TMUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABT
  • TMUS
  • Stock Information
  • Founded
  • ABT 1888
  • TMUS 1994
  • Country
  • ABT United States
  • TMUS United States
  • Employees
  • ABT N/A
  • TMUS N/A
  • Industry
  • ABT Medical/Dental Instruments
  • TMUS Telecommunications Equipment
  • Sector
  • ABT Health Care
  • TMUS Telecommunications
  • Exchange
  • ABT Nasdaq
  • TMUS Nasdaq
  • Market Cap
  • ABT 231.5B
  • TMUS 236.3B
  • IPO Year
  • ABT N/A
  • TMUS N/A
  • Fundamental
  • Price
  • ABT $124.20
  • TMUS $210.93
  • Analyst Decision
  • ABT Strong Buy
  • TMUS Buy
  • Analyst Count
  • ABT 18
  • TMUS 16
  • Target Price
  • ABT $146.61
  • TMUS $266.44
  • AVG Volume (30 Days)
  • ABT 6.0M
  • TMUS 5.3M
  • Earning Date
  • ABT 10-15-2025
  • TMUS 10-23-2025
  • Dividend Yield
  • ABT 1.90%
  • TMUS 1.94%
  • EPS Growth
  • ABT 141.97
  • TMUS 18.54
  • EPS
  • ABT 7.96
  • TMUS 10.38
  • Revenue
  • ABT $43,843,000,000.00
  • TMUS $85,847,000,000.00
  • Revenue This Year
  • ABT $7.55
  • TMUS $10.53
  • Revenue Next Year
  • ABT $7.70
  • TMUS $7.34
  • P/E Ratio
  • ABT $15.57
  • TMUS $20.28
  • Revenue Growth
  • ABT 6.37
  • TMUS 7.30
  • 52 Week Low
  • ABT $110.86
  • TMUS $199.41
  • 52 Week High
  • ABT $141.23
  • TMUS $276.49
  • Technical
  • Relative Strength Index (RSI)
  • ABT 38.35
  • TMUS 42.21
  • Support Level
  • ABT $124.55
  • TMUS $199.41
  • Resistance Level
  • ABT $132.03
  • TMUS $218.33
  • Average True Range (ATR)
  • ABT 2.47
  • TMUS 4.16
  • MACD
  • ABT 0.19
  • TMUS 1.22
  • Stochastic Oscillator
  • ABT 20.19
  • TMUS 60.65

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

About TMUS T-Mobile US Inc.

Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 85 million postpaid and 26 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 7 million residential and business customers with its wireless network. It also serves nearly 1 million fiber broadband customers through joint ventures with fiber network owners. T-Mobile owns a stake in these firms, which provide wholesale access to their networks. In addition, T-Mobile provides wholesale services to wireless resellers.

Share on Social Networks: